Voorbeelden van het gebruik van Peginterferon in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
In the ELECTRON study(N 11), the duration of peginterferon alfa ranged from 4-12 weeks in combination with sofosbuvir+ ribavirin.
Some people have bleeding in the digestive system after they stop taking peginterferon, ribavirin, and Revolade.
Each haemodialysis reduced peginterferon beta-1a concentration by approximately 24%,
ENABLE 1 utilised peginterferon alfa-2a plus ribavirin for antiviral treatment and ENABLE 2 utilised peginterferon alfa-2b plus ribavirin.
The combination can also be used to treat adults who have already failed treatment with an interferon alpha or peginterferon alpha in combination with ribavirin or interferon alpha alone.
Exposure at this dose was comparable to the exposure in HCV-infected patients receiving a dose of 750 mg INCIVO every 8 hours plus peginterferon alfa and ribavirin.
TE treatment-experienced patients including those who have failed a peginterferon alfa+ ribavirin based regimen with or without an HCV protease inhibitor.
suggest that age does not impact peginterferon beta-1a clearance.
one with ribavirin+ peginterferon alfa-2b C/I98-580.
which may lead to loss of teeth, have been reported in patients receiving Ribavirin and peginterferon alfa-2b or interferon alfa-2b combination therapy.
one with Ribavirin+ peginterferon alfa-2b C/ I98-580.
null responders for peginterferon alfa/ribavirin), unless specific dose recommendations are given refer to table 2.
Reminder: Please also read the“Do not use” section of the Package Leaflets for peginterferon alfa and ribavirin before you start taking Victrelis.
was reported following discontinuation of peginterferon, ribavirin, and eltrombopag.
the following other side effects have occurred with the combination of ribavirin and peginterferon alfa-2b not listed above in adults side effects.
Treatment with OLYSIO must be initiated in combination with peginterferon alfa+ ribavirin and administered for 12 weeks and then followed by an additional 12 weeks of peginterferon alfa+ ribavirin.
48 weeks of peginterferon alfa-2a and ribavirin treatment.
Each pre-filled pen of ViraferonPeg 50 micrograms contains a sufficient amount of peginterferon alfa-2b as measured on a protein basis in a powder for solution for injection,
75 kg received 100 µg/week peginterferon alfa-2b and subjects≥ 75 kg received 150 µg/week peginterferon alfa-2b.
for the shortened 24 week peginterferon/ribavirin treatment duration versus 61.7%(50/81)